Abstract |
Galectin-1 (Gal-1), a member of the galectin family of carbohydrate binding proteins, plays a pivotal role in various cellular processes of tumorigenesis. The regulatory effect of Gal-1 on multidrug resistance (MDR) breast cancer cells is still unclear. qRT-PCR and western blot showed that Gal-1 and MDR gene 1 (MDR1) were both highly expressed in breast tumor tissues and cell lines. MTT assay and flow cytometry revealed that Gal-1 knockdown improved sensitivity to paclitaxel (PTX) and adriamycin (ADR) in MCF-7/PTX and MCF-7/ADR cells via inhibition of cell viability and promotion of cell apoptosis, while MDR1 overexpression weakened the sensitivity to PTX and ADR induced by Gal-1 knockdown. Furthermore, the negative effects of Gal-1 knockdown on sensitivity to PTX and ADR in MCF-7/PTX and MCF-7/ADR cells were revealed to be mediated via the suppression of Raf-1/AP-1 pathway. In conclusion, Gal-1 knockdown dramatically improved drug sensitivity of breast cancer by reducing P-glycoprotein (P-gp) expression via inhibiting the Raf-1/AP-1 pathway, providing a novel therapeutic target to overcome MDR in breast cancer.
|
Authors | Fang Wang, Pengwei Lv, Yuanting Gu, Lin Li, Xin Ge, Guangcheng Guo |
Journal | Oncotarget
(Oncotarget)
Vol. 8
Issue 15
Pg. 25097-25106
(Apr 11 2017)
ISSN: 1949-2553 [Electronic] United States |
PMID | 28212576
(Publication Type: Journal Article)
|
Chemical References |
- ATP Binding Cassette Transporter, Subfamily B, Member 1
- Antineoplastic Agents
- Galectin 1
- Transcription Factor AP-1
- Proto-Oncogene Proteins c-raf
|
Topics |
- ATP Binding Cassette Transporter, Subfamily B, Member 1
(genetics)
- Antineoplastic Agents
(pharmacology)
- Apoptosis
(drug effects)
- Cell Line, Tumor
- Cell Survival
(drug effects, genetics)
- Drug Resistance, Multiple
(drug effects, genetics)
- Drug Resistance, Neoplasm
(genetics)
- Female
- Galectin 1
(genetics)
- Gene Expression Regulation, Neoplastic
- Gene Knockdown Techniques
- Humans
- Proto-Oncogene Proteins c-raf
(metabolism)
- Signal Transduction
(drug effects)
- Transcription Factor AP-1
(metabolism)
|